However, in subgroup analysis, we found that treatment with PDE-5 inhibitors but not with other drugs could improve DLCO in patients with COPD (MD = 6.56 [95% CI (1.74, 11.39)], P = .008), as shown in Figure 4. This evidence concerns the gene PDE5A and chronic obstructive pulmonary disease.